These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Kyzatrex - Oral testosterone replacement therapy. Asghar AA; Hashmi MR; Ahmed R; Khabir Y Ann Med Surg (Lond); 2022 Oct; 82():104625. PubMed ID: 36268410 [No Abstract] [Full Text] [Related]
48. Gender-Specific Impact of Sex Hormones on the Immune System. Sciarra F; Campolo F; Franceschini E; Carlomagno F; Venneri MA Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047274 [TBL] [Abstract][Full Text] [Related]
49. Androgen and Androgen Receptors as Regulators of Monocyte and Macrophage Biology in the Healthy and Diseased Lung. Becerra-Diaz M; Song M; Heller N Front Immunol; 2020; 11():1698. PubMed ID: 32849595 [TBL] [Abstract][Full Text] [Related]
50. Sex influences DNA methylation and gene expression in human skeletal muscle myoblasts and myotubes. Davegårdh C; Hall Wedin E; Broholm C; Henriksen TI; Pedersen M; Pedersen BK; Scheele C; Ling C Stem Cell Res Ther; 2019 Jan; 10(1):26. PubMed ID: 30646953 [TBL] [Abstract][Full Text] [Related]
51. Do Androgens Modulate the Pathophysiological Pathways of Inflammation? Appraising the Contemporary Evidence. Traish A; Bolanos J; Nair S; Saad F; Morgentaler A J Clin Med; 2018 Dec; 7(12):. PubMed ID: 30558178 [TBL] [Abstract][Full Text] [Related]
52. Increased frequencies of circulating CXCL10-, CXCL8- and CCL4-producing monocytes and Siglec-3-expressing myeloid dendritic cells in systemic sclerosis patients. Carvalheiro T; Horta S; van Roon JAG; Santiago M; Salvador MJ; Trindade H; Radstake TRDJ; da Silva JAP; Paiva A Inflamm Res; 2018 Feb; 67(2):169-177. PubMed ID: 29127442 [TBL] [Abstract][Full Text] [Related]
53. Sex-based differences in immune function and responses to vaccination. Klein SL; Marriott I; Fish EN Trans R Soc Trop Med Hyg; 2015 Jan; 109(1):9-15. PubMed ID: 25573105 [TBL] [Abstract][Full Text] [Related]
54. Enhanced immunological response by dendritic cells in male hypogonadism. Corrales JJ; Almeida M; Cordero M; Martín-Martín L; Méndez C; Miralles JM; Orfao A Eur J Clin Invest; 2012 Nov; 42(11):1205-12. PubMed ID: 22957648 [TBL] [Abstract][Full Text] [Related]
55. Persistence of androgenic effects on the production of proinflammatory cytokines by circulating antigen-presenting cells after withdrawal of testosterone treatment in aging type 2 diabetic men with partial androgen deficiency. Corrales JJ; Almeida M; Miralles JM; Orfao A Fertil Steril; 2009 Jul; 92(1):311-9. PubMed ID: 18710716 [TBL] [Abstract][Full Text] [Related]
56. Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism. Liao CH; Wu YN; Lin FY; Tsai WK; Liu SP; Chiang HS Andrology; 2013 Jul; 1(4):563-9. PubMed ID: 23653307 [TBL] [Abstract][Full Text] [Related]
57. Testosterone administration in older men. Matsumoto AM Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401 [TBL] [Abstract][Full Text] [Related]
58. Testosterone replacement in older men and women. Morley JE J Gend Specif Med; 2001; 4(2):49-53. PubMed ID: 11480098 [TBL] [Abstract][Full Text] [Related]
59. Testosterone replacement therapy in hypogonadal men is associated with increased expression of LAMP-2 (CD107b) by circulating monocytes and dendritic cells. Corrales JJ; Almeida M; Martín-Martín L; Miralles JM; Orfao A Clin Endocrinol (Oxf); 2014 Apr; 80(4):577-84. PubMed ID: 24111582 [TBL] [Abstract][Full Text] [Related]